Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 11 studies | 38% ± 16% | |
glutamatergic neuron | 9 studies | 56% ± 24% | |
neuron | 8 studies | 29% ± 13% | |
fibroblast | 8 studies | 39% ± 19% | |
adipocyte | 7 studies | 48% ± 26% | |
GABAergic neuron | 6 studies | 43% ± 20% | |
astrocyte | 6 studies | 36% ± 15% | |
oligodendrocyte | 6 studies | 32% ± 11% | |
endothelial cell | 5 studies | 54% ± 27% | |
microglial cell | 5 studies | 30% ± 4% | |
cardiac muscle cell | 5 studies | 40% ± 14% | |
T cell | 5 studies | 32% ± 27% | |
endothelial cell of lymphatic vessel | 5 studies | 40% ± 24% | |
macrophage | 5 studies | 31% ± 10% | |
pericyte | 5 studies | 27% ± 5% | |
smooth muscle cell | 5 studies | 28% ± 11% | |
interneuron | 4 studies | 35% ± 14% | |
ciliated cell | 4 studies | 56% ± 28% | |
club cell | 4 studies | 53% ± 25% | |
type I pneumocyte | 4 studies | 55% ± 18% | |
type II pneumocyte | 4 studies | 50% ± 21% | |
retina horizontal cell | 3 studies | 26% ± 9% | |
endocardial cell | 3 studies | 33% ± 20% | |
mesothelial cell | 3 studies | 45% ± 8% | |
natural killer cell | 3 studies | 19% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5967.16 | 2640 / 2642 | 99% | 96.63 | 695 / 705 |
breast | 71% | 431.47 | 328 / 459 | 61% | 16.19 | 679 / 1118 |
kidney | 75% | 414.64 | 67 / 89 | 49% | 7.22 | 441 / 901 |
ovary | 37% | 204.92 | 66 / 180 | 85% | 28.74 | 367 / 430 |
skin | 37% | 184.72 | 672 / 1809 | 79% | 33.67 | 372 / 472 |
uterus | 81% | 555.67 | 137 / 170 | 26% | 5.24 | 121 / 459 |
eye | 0% | 0 | 0 / 0 | 79% | 19.57 | 63 / 80 |
adrenal gland | 11% | 52.12 | 29 / 258 | 65% | 23.15 | 150 / 230 |
bladder | 52% | 242.90 | 11 / 21 | 13% | 1.88 | 63 / 504 |
adipose | 64% | 381.42 | 772 / 1204 | 0% | 0 | 0 / 0 |
thymus | 46% | 211.95 | 303 / 653 | 17% | 1.69 | 104 / 605 |
spleen | 63% | 292.03 | 152 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 60% | 573.00 | 802 / 1335 | 0% | 0 | 0 / 0 |
intestine | 37% | 171.34 | 361 / 966 | 19% | 2.42 | 98 / 527 |
heart | 55% | 512.10 | 477 / 861 | 0% | 0 | 0 / 0 |
prostate | 26% | 111.90 | 64 / 245 | 20% | 2.49 | 99 / 502 |
esophagus | 12% | 51.17 | 167 / 1445 | 24% | 3.40 | 44 / 183 |
stomach | 9% | 43.97 | 33 / 359 | 24% | 3.53 | 70 / 286 |
lung | 8% | 34.72 | 47 / 578 | 22% | 3.42 | 252 / 1155 |
pancreas | 16% | 59.14 | 54 / 328 | 13% | 2.06 | 23 / 178 |
liver | 1% | 3.38 | 2 / 226 | 23% | 5.10 | 94 / 406 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.43 | 2 / 45 |
muscle | 1% | 4.87 | 10 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.36 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005615 | Cellular component | extracellular space |
GO_0005886 | Cellular component | plasma membrane |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005154 | Molecular function | epidermal growth factor receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LINGO1 |
Protein name | Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (Leucine-rich repeat and immunoglobulin domain-containing protein 1) (Leucine-rich repeat neuronal protein 1) (Leucine-rich repeat neuronal protein 6A) Leucine rich repeat and Ig domain containing 1 |
Synonyms | LRRN6A LERN1 UNQ201/PRO227 |
Description | FUNCTION: Functional component of the Nogo receptor signaling complex (RTN4R/NGFR) in RhoA activation responsible for some inhibition of axonal regeneration by myelin-associated factors . Is also an important negative regulator of oligodentrocyte differentiation and axonal myelination . Acts in conjunction with RTN4 and RTN4R in regulating neuronal precursor cell motility during cortical development (By similarity). . |
Accessions | ENST00000561030.5 [Q96FE5-2] ENST00000564472.5 H3BMN3 ENST00000570216.5 H3BN48 Q96FE5 H3BQ49 ENST00000559893.5 ENST00000557798.1 H0YMX3 H0YNK7 ENST00000566711.5 ENST00000562933.5 ENST00000561686.5 ENST00000355300.7 [Q96FE5-1] H3BS32 H3BMW2 ENST00000567726.5 H3BM59 |